SCHEMBL9451693

SCHEMBL9451693

C#Cc1ccnc2[nH]c(NC(=O)C(C)(C)C)nc(=O)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPT P10636 2/20 0.33
TP53 P04637 1/20 0.33
ALK Q9UM73 1/20 0.33
PDGFRB P09619 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
EGFR P00533 3/20 0.32
KDR P35968 3/20 0.32
LMNA P02545 1/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
TSHR P16473 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9451547 0.85 LCK (0.39) ALK
SCHEMBL9451696 0.82 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL9451550 0.68 LCK (0.38) SMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL27593194 0.65 ALDH1A1 (0.49) SMN1; SMN2ALDH1A1HPGDLMNAKDM4E
SCHEMBL1335315 0.64 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL7878824 0.64 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL6896283 0.64 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDMAPTTP53
SCHEMBL18623608 0.63 LMNA (0.69) SMN1; SMN2ALDH1A1CYP3A4TP53LMNA
SCHEMBL1366483 0.63 PDGFRB (0.57) SMN1; SMN2ALDH1A1HPGDPDGFRBEGFR
Benzene SCHEMBL14840511 0.63 POLB (0.39) SMN1; SMN2TP53L3MBTL1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567223-A1 Glutamic acid derivatives as antineoplastic agents ELI LILLY AND COMPANY (US) 1993-10-27 EP disclosed
US-5196424-A Antitumor ELI LILLY AND COMPANY (US) 1993-03-23 US disclosed